Elevai Labs Inc. (NASDAQ:ELAB) price on Friday, October 25, rose 9.87% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.10.
A look at the stock’s price movement, the close in the last trading session was $0.09, moving within a range at $0.0975 and $0.184. Turning to its 52-week performance, $4.24 and $0.08 were the 52-week high and 52-week low respectively. Overall, ELAB moved 13.82% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elevai Labs Inc.’s market cap currently stands at around $2.11 million, with investors looking forward to this quarter’s earnings report slated for in November.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ELAB is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
ELAB’s current price about 4.82% and -48.26% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.67, while 7-day volatility ratio is 38.73% and 19.21% in the 30-day chart. Further, Elevai Labs Inc. (ELAB) has a beta value of 0, and an average true range (ATR) of 0.03.
If we refocus on Elevai Labs Inc. (NASDAQ:ELAB), historical trading data shows that trading volumes averaged 14.31 over the past 10 days and 16.30 million over the past 3 months. The company’s latest data on shares outstanding shows there are 17.33 million shares.
The 20.30% of Elevai Labs Inc.’s shares are in the hands of company insiders while institutional holders own 22.89% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.69 million on 2024-09-30, giving us a short ratio of 0.07. The data shows that as of 2024-09-30 short interest in Elevai Labs Inc. (ELAB) stood at 306.0 of shares outstanding, with shares short falling to 0.87 million registered in 2024-08-30. Current price change has pushed the stock -94.46% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ELAB stock continues to rise going into the next quarter.
